Financhill
Back

RxSight 10K Form

Sell
12

RXST
RxSight

Last Price:
$14.52
Seasonality Move:
33.86%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RXST News And Ratings

See the #1 stock for the next 7 days that we like better than RXST

RXST Financial Statistics

Sales & Book Value

Annual Sales: $139.9M
Cash Flow: $-5.1M
Price / Cash Flow: 0
Annual Sales: $6.96
Price / Book: 2.1

Profitability

EPS (TTM): -0.72000
Net Income (TTM): $-27.5M
Gross Margin: $98.9M
Return on Equity: -11.86%
Return on Assets: -10.56%

RxSight Earnings Forecast

Key RxSight Financial Ratios

  • The Gross Profit Margin over the past 6 years for RXST is 70.71%.
  • The Selling, General & Administrative Expenses for RXST have been equal to 72.49% of Gross Profit Margin.
  • The Research & Development expenses have been 24.56% of Revenue.
  • The Net Earning history of RXST is -19.62% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 3 years.

RxSight Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: RXST
Website: rxsight.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 11.36
Quick Ratio: 10.33

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 215.16

RXST Technical Analysis vs Fundamental Analysis

Sell
12
RxSight (RXST) is a Sell

Is RxSight a Buy or a Sell?

  • RxSight stock is rated a Sell
    The current RxSight [RXST] share price is $14.62. The Score for RXST is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.